OncoTherics Poland updates progress at LSBC 2019, Krakow
Author:
OncoTherics
Investment opportunity
OncoTherics welcomes discussions with investors and strategic partners interested in our unidirectional hypoxia-activated prodrug programmes.
Please leave your details below to arrange a conversation about the company and its investment opportunity.
Are you a researcher?
Are you working on a project where OncoTherics' technology might be of help or would you like to collaborate in our research? Please provide your contact details so that we can include you on our contact list.